GLAUCOMA, DRY EYE AND ZIMED


Associated tags: Patient, Glaucoma, Health Canada, Dry eye syndrome, Environment, Ocular hypertension, Eye, Allergy, Optic nerve, Paratriathlon, IOP, OTCQB, Physician, AQS, Pharmaceutical industry, Pharmacy, Telecanthus, COS

Locations: CANADA

Aequus Announces Zimed PF Now Available in Canada

Retrieved on: 
Thursday, August 24, 2023
Glaucoma, OTCQB, Physician, AQS, Patient, Pharmacy, Pharmaceutical industry

VANCOUVER, British Columbia, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS , OTCQB: AQSZF ), ) (“Aequus” or the “Company”), a specialty pharmaceutical company announced today, we are thrilled to announce the launch of Zimed® PF, the first preservative-free multi-dose Bimatoprost for glaucoma patients in Canada.

Key Points: 
  • VANCOUVER, British Columbia, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS , OTCQB: AQSZF ), ) (“Aequus” or the “Company”), a specialty pharmaceutical company announced today, we are thrilled to announce the launch of Zimed® PF, the first preservative-free multi-dose Bimatoprost for glaucoma patients in Canada.
  • "This marks a new growth phase for Aequus and the launch of a Preservative Free (PF) innovation that brings value to both physicians and patients in a large therapeutic eye category,” says Grant Larsen, Chief Commercial Officer for Aequus Pharmaceuticals Inc. Canada.
  • “An exciting product innovation, launched in multiple countries around the world, this product will be available at pharmacies across Canada in the coming weeks.”
    For more information, please visit www.ZimedPF.ca and join us in celebrating this milestone in glaucoma treatment.

Aequus Announces Zimed PF Website Launch

Retrieved on: 
Tuesday, August 22, 2023
Glaucoma, Telecanthus, OTCQB, COS, Physician, Patient, AQS, Pharmaceutical industry

VANCOUVER, British Columbia, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS , OTCQB: AQSZF ), ) (“Aequus” or the “Company”), a specialty pharmaceutical company, are thrilled to announce the launch of our user friendly education website for patients and professionals.

Key Points: 
  • VANCOUVER, British Columbia, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS , OTCQB: AQSZF ), ) (“Aequus” or the “Company”), a specialty pharmaceutical company, are thrilled to announce the launch of our user friendly education website for patients and professionals.
  • With a focus on elevated, interocular pressure, Glaucoma and Dry Eye Disease, this website features Zimed® PF, the first preservative-free multi-dose Bimatoprost available in Canada.
  • With an emphasis on user-friendly navigation and an engaging interface, the website ensures a seamless experience for all visitors.
  • "We are proud to bring this long-awaited innovation to the Canadian glaucoma community," said Doug Janzen, CEO of Aequus Pharma Canada.